Revolutionary Gene Therapy Platform
Oracles BioTech unveils groundbreaking gene therapy technology with potential to treat rare genetic disorders. Our proprietary delivery system shows unprecedented efficacy in preclinical models.
Read MoreOracles BioTech leads the way in biotechnology research and pharmaceutical development, delivering breakthrough solutions that improve lives worldwide.
Leveraging cutting-edge technology and AI to revolutionize healthcare delivery and patient outcomes.
Explore →
World-class team of physicians, researchers, and scientists dedicated to advancing medical breakthroughs.
Discover →
State-of-the-art laboratories equipped with the latest technology for groundbreaking research.
Learn More →Clinical Trials Completed
Countries Served
Years of Experience
FDA Approvals
Oracles BioTech unveils groundbreaking gene therapy technology with potential to treat rare genetic disorders. Our proprietary delivery system shows unprecedented efficacy in preclinical models.
Read More
New biotechnology platform accelerates drug development and reduces time to market for critical therapies. Our innovative approach has demonstrated a 40% reduction in development timelines.
Read More
Oracles BioTech reports positive results from pivotal Phase III study for innovative cancer immunotherapy. The trial met all primary and secondary endpoints with a favorable safety profile.
Read MoreWith operations in over 50 countries, Oracles BioTech delivers world-class biotechnology solutions on a global scale
Research center in Boston (33 Avenue Louis Pasteur, Boston, MA 02116, United States)
Operations in Türkiye (No: 375, Naldöken, Ankara Asfaltı Cd. No:375, 35050 Bornova, Türkiye) and Switzerland (Thurgauerstrasse 131, 8152 Glattpark (Opfikon), Switzerland)
Presence in Japan (15 Kisshoin Nishinosho Monguchicho, Minami Ward, Kyoto) and Singapore (8 Yishun Industrial Street 2, North Spring BizHub)